409 results on '"Spaulding, Anne C"'
Search Results
52. Correlates of Retention in HIV Care After Release from Jail: Results from a Multi-site Study
53. Planning for Success Predicts Virus Suppressed: Results of a Non-Controlled, Observational Study of Factors Associated with Viral Suppression Among HIV-Positive Persons Following Jail Release
54. Cost Analysis of Enhancing Linkages to HIV Care Following Jail: A Cost-Effective Intervention
55. Adherence to HIV Treatment and Care Among Previously Homeless Jail Detainees
56. Jails, HIV Testing, and Linkage to Care Services: An Overview of the EnhanceLink Initiative
57. Aiming for Zero: Reducing Transmission of Coronavirus Disease 2019 in the D.C. Department of Corrections
58. HIV-Related Research in Correctional Populations: Now is the Time
59. History of Arrest and Associated Factors among Men Who Have Sex with Men
60. Predictors of reincarceration and disease progression among released HIV-infected inmates
61. Late surges in COVID-19 cases and varying transmission potential partially due to public health policy changes in 5 Western states, March 10, 2020-January 10, 2021
62. Spatially refined time-varying reproduction numbers of SARS-CoV-2 in Arkansas and Kentucky and their relationship to population size and public health policy, March – November, 2020
63. Prisoners treated for hepatitis C with protease inhibitor, New York, USA, 2012
64. Re: “Derivation and Validation of the Denver Human Immunodeficiency Virus (HIV) Risk Score for Targeted HIV Screening”
65. Screening for HCV Infection in Jails
66. Diversity of Release Patterns for Jail Detainees: Implications for Public Health Interventions
67. Prisoner Survival Inside and Outside of the Institution: Implications for Health-Care Planning
68. Control of epidemics by jails: lessons for COVID-19 from HIV
69. Flattening the Curve for Incarcerated Populations — Covid-19 in Jails and Prisons
70. Prisons can also improve drug user health in the community
71. PRIOR REPORTS OF MEDICAL PROBLEMS AMONG INMATES
72. Mortality after Release from Prison
73. A Framework for Management of Hepatitis C in Prisons
74. Treatment of Chronic Hepatitis C in a State Correctional Facility
75. Capsule Commentary on Rich et al., Higher Standards in Correctional Healthcare Could Improve Public Health
76. The Mortality After Release from Incarceration Consortium (MARIC): Protocol for a multi-national, individual participant data meta-analysis
77. Assessment and Comparison of Hepatitis C Viremia in the Prison Systems of New Mexico and Georgia
78. Letter to the Editor: Hepatitis C Virus Prevalence Estimates Among Incarcerated Persons
79. The impact of direct-acting anti-virals on the hepatitis C care cascade: identifying progress and gaps towards hepatitis C elimination in the United States
80. In Search of Denominators
81. Lessons from HIV deaths after incarceration
82. Measuring Correctional Experience to Inform Development of HIV, Sexually Transmitted Infection, and Substance Use Interventions for Incarcerated Black Men Who Have Sex with Men
83. The Names Have Been Changed to Protect the . . . Humanity: Person-First Language in Correctional Health Epidemiology
84. Jail, an unappreciated medical home: Assessing the feasibility of a strengths-based case management intervention to improve the care retention of HIV-infected persons once released from jail
85. Smoking in Correctional Settings Worldwide: Prevalence, Bans, and Interventions
86. HIV and HCV in U.S. Prisons and Jails: The Correctional Facility as a Bellwether Over Time for the Community’s Infections
87. The Missing Link: HIV, Corrections, and Public Health
88. Where is the US Hepatitis C Epidemic *Now*? Putting the “Pen” on the Map as Elimination Efforts Hunt for Remaining Cases.
89. Rasch Analysis and Differential Item Functioning of a Social Support Measure in Jail Inmates With HIV Infection
90. Apportioning blame in the North American hepatitis C virus epidemic
91. Retrospective cohort study of cancer incidence and mortality by HIV status in a Georgia, USA, prisoner cohort during the HAART era
92. Funding Hepatitis C Treatment in Correctional Facilities by Using a Nominal Pricing Mechanism.
93. Receipt of A(H1N1)pdm09 vaccine by prisons and jails--United States, 2009-10 influenza season
94. A Call to Action: A Blueprint for Academic Health Sciences in the Era of Mass Incarceration
95. Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons
96. HIV-infected men who have sex with men, before and after release from jail: the impact of age and race, results from a multi-site study
97. Costs of Rapid HIV Screening in an Urban Emergency Department and a Nearby County Jail in the Southeastern United States
98. Focus on testing, not shifting blame
99. Distribution of A(H1N1)pdm09 Influenza Vaccine
100. Hepatitis C Seroprevalence among Prison Inmates since 2001: Still High but Declining
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.